Optimizing Patient Outcomes with Adjunctive OTC Skincare

JDD Multimedia

Join Dr. Ted Lain, Chief Medical Officer at Sanova Dermatology, and Star Walsh, R&D Director at Neutrogena®, for an informative webinar on the latest science and role of adjunctive OTC skincare in optimizing patient outcomes. Explore Hydro Boost Technologies and the latest findings on pre/post-procedure care & complementary Rx support. Discover valuable insights from the science behind Neutrogena®.

Faculty

Ted Lain, MD
Chief Medical Officer at Sanova Dermatology
Executive Director at Austin Institute for Clinical Research
Austin, Texas

Star Walsh
R&D Director at Neutrogena® Skin Health

Watch On Demand

APP-solutely Essential: Putting Corticosteroid Stewardship Into Practice

Mikaela Sonis | Featured Articles, Featured Podcast, Global Steroidal Stewardship, Latest News, Podcast, Podcast Highlights | No Comments

Guest: Douglas DiRuggiero Corticosteroids remain one of dermatology’s most reliable workhorses, but good stewardship isn’t about putting the horse out to pasture. It’s about knowing when to ride, when to…

Shots, Shots, Shots: Is There Such a Thing as One Too Many?

Mikaela Sonis | Featured Articles, Featured Podcast, Latest News, Podcast, Podcast Highlights | No Comments

Guest: Dr. Joseph Bax Corticosteroid injections are everywhere in musculoskeletal medicine. Epidurals, joints, facets, bursae: when inflammation and pain are the targets, steroids have long been one of the sharpest…

F around and Find Out: Failing Forward, IL-17F in Focus, and Finding New Treatment Paradigms and Friendships through Industry Collaborations

Mikaela Sonis | Featured Articles, Featured Podcast, Latest News, Podcast, Podcast Highlights | No Comments

Guest: Dr. Tae Oh For too long, the therapeutic ladder in hidradenitis suppurativa has often looked less like a ladder and more like an uneven mound: try this, fail that,…